CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

November 12, 2021 · earnings

RLMD earnings: a negative outcome, -11.1%

On November 12, 2021, RELMADA THERAPEUTICS, INC. reached its earnings. The result was a negative outcome, and the stock moved -11.1% in the window around the event.

The move

$25.66
1d before
$22.82
Event day
$22.82
1d after
$21.45
5d after

Pre-catalyst setup

+1.2%
30-day run-up
3922%
30-day volatility
0.7×
volume spike